New Zealand vs Norway: Number of isolates tested for ceftriaxone
New Zealand
861
in 2020
Norway
450
in 2020
New Zealand rank
7th
Norway rank
8th
Number of isolates tested for ceftriaxone over time
- New Zealand
- Norway
How they compare
New Zealand currently reports 861 against 450 in Norway, a difference of 411.
That makes New Zealand's figure about 1.9 times Norway's.
Across all 9 years both countries report, New Zealand has been ahead every year.
New Zealand ranks 7th and Norway ranks 8th of 52 countries.
New Zealand has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | New Zealand | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 234 | 110 | 124 | New Zealand |
| 2010s | 383.14 | 96.14 | 287 | New Zealand |
| 2020s | 861 | 450 | 411 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, New Zealand or Norway?
- New Zealand, at 861 against 450 in Norway as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between New Zealand and Norway?
- 411, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Norway?
- 9 years are reported by both, from 2009 to 2020.
- How do New Zealand and Norway rank globally for number of isolates tested for ceftriaxone?
- New Zealand ranks 7th and Norway ranks 8th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.